The Arab Drug Company (EGX:ADCI)
Egypt · Delayed Price · Currency is EGP 254.67
-1.52 (-0.59%)
At close: Oct 22, 2026
The Arab Drug Company Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 119.73 | 79.28 | 232.72 | 50.48 | 40.28 |
Cash & Short-Term Investments | 119.73 | 79.28 | 232.72 | 50.48 | 40.28 |
Cash Growth | 51.02% | -65.93% | 361.00% | 25.33% | -33.21% |
Accounts Receivable | 77.98 | 130.06 | 71.44 | 69.72 | 54.02 |
Other Receivables | 99.39 | 76.36 | 48.45 | 20.11 | 28.91 |
Receivables | 341.22 | 287.39 | 203.53 | 173.07 | 153.86 |
Inventory | 366.8 | 327.72 | 236.28 | 254.09 | 224.85 |
Prepaid Expenses | - | - | 0.01 | - | 0.11 |
Other Current Assets | 0.84 | 0.74 | 0.34 | 0.41 | 0.43 |
Total Current Assets | 828.58 | 695.12 | 672.88 | 478.05 | 419.53 |
Property, Plant & Equipment | 692.84 | 616.53 | 444.4 | 193.36 | 145.5 |
Long-Term Investments | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 |
Long-Term Deferred Tax Assets | 6.2 | 8.98 | 14.06 | 8.39 | 6.7 |
Other Long-Term Assets | - | - | -0 | - | -0 |
Total Assets | 1,530 | 1,323 | 1,134 | 682.07 | 573.98 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 102.43 | 64.52 | 45.63 | 44.18 | 25.26 |
Accrued Expenses | 11.17 | 10.22 | 11.63 | 11.14 | 9.02 |
Short-Term Debt | 267.9 | 174.41 | 116.7 | 85.26 | 98.66 |
Current Portion of Long-Term Debt | 91.87 | 91.44 | 73.37 | - | - |
Current Income Taxes Payable | 51.79 | 47.99 | 24.42 | 6.33 | 2.41 |
Other Current Liabilities | 52.96 | 68.26 | 76.3 | 45.11 | 46.01 |
Total Current Liabilities | 578.11 | 456.83 | 348.04 | 192.03 | 181.36 |
Long-Term Debt | 194.6 | 245.35 | 324.88 | 103.71 | 52.41 |
Long-Term Leases | 5.89 | 0.96 | 2.15 | 3.1 | - |
Other Long-Term Liabilities | - | - | - | 0 | - |
Total Liabilities | 778.61 | 703.15 | 675.06 | 298.84 | 233.78 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 120 | 120 | 60 | 60 | 60 |
Retained Earnings | 609.98 | 478.45 | 377.23 | 301.94 | 258.91 |
Comprehensive Income & Other | 21.3 | 21.3 | 21.3 | 21.3 | 21.3 |
Shareholders' Equity | 751.28 | 619.74 | 458.53 | 383.23 | 340.21 |
Total Liabilities & Equity | 1,530 | 1,323 | 1,134 | 682.07 | 573.98 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 560.26 | 512.16 | 517.09 | 192.07 | 151.07 |
Net Cash (Debt) | -440.53 | -432.88 | -284.38 | -141.59 | -110.8 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -36.71 | -36.07 | -23.70 | -11.80 | -8.18 |
Filing Date Shares Outstanding | 12 | 12 | 12 | 12 | 12 |
Total Common Shares Outstanding | 12 | 12 | 12 | 12 | 12 |
Working Capital | 250.47 | 238.29 | 324.84 | 286.03 | 238.17 |
Book Value Per Share | 62.61 | 51.65 | 38.21 | 31.94 | 28.35 |
Tangible Book Value | 751.28 | 619.74 | 458.53 | 383.23 | 340.21 |
Tangible Book Value Per Share | 62.61 | 51.65 | 38.21 | 31.94 | 28.35 |
Land | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
Buildings | 273.07 | 272.24 | 82.98 | 61.47 | 61.44 |
Machinery | 217.72 | 208.66 | 145.17 | 124.79 | 124.52 |
Construction In Progress | 410.65 | 318.45 | 372.62 | 154.6 | 101.16 |